466 related articles for article (PubMed ID: 15232137)
1. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
[TBL] [Abstract][Full Text] [Related]
2. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
4. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
5. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors.
Webster JD; Kiupel M; Yuzbasiyan-Gurkan V
BMC Cancer; 2006 Apr; 6():85. PubMed ID: 16579858
[TBL] [Abstract][Full Text] [Related]
8. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008).
Schwab TM; Popovitch C; DeBiasio J; Goldschmidt M
J Am Anim Hosp Assoc; 2014; 50(3):187-91. PubMed ID: 24659731
[TBL] [Abstract][Full Text] [Related]
10. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
[TBL] [Abstract][Full Text] [Related]
11. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.
Preziosi R; Morini M; Sarli G
J Vet Diagn Invest; 2004 Nov; 16(6):554-61. PubMed ID: 15586571
[TBL] [Abstract][Full Text] [Related]
12. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
[TBL] [Abstract][Full Text] [Related]
13. Mast cell tumors of the gastrointestinal tract in 39 dogs.
Ozaki K; Yamagami T; Nomura K; Narama I
Vet Pathol; 2002 Sep; 39(5):557-64. PubMed ID: 12243465
[TBL] [Abstract][Full Text] [Related]
14. Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome.
Camus MS; Priest HL; Koehler JW; Driskell EA; Rakich PM; Ilha MR; Krimer PM
Vet Pathol; 2016 Nov; 53(6):1117-1123. PubMed ID: 27034386
[TBL] [Abstract][Full Text] [Related]
15. Receptor Tyrosine Kinase Expression Profiles in Canine Cutaneous and Subcutaneous Mast Cell Tumors.
Thompson JJ; Morrison JA; Pearl DL; Boston SE; Wood GA; Foster RA; Coomber BL
Vet Pathol; 2016 May; 53(3):545-58. PubMed ID: 26459517
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors.
Jaffe MH; Hosgood G; Taylor HW; Kerwin SC; Hedlund CS; Lopez MK; Davidson JR; Miller DM; Paranjpe M
Vet Pathol; 2000 Jan; 37(1):40-6. PubMed ID: 10643979
[TBL] [Abstract][Full Text] [Related]
17. Comparison of serum tryptase as a diagnostic oncological marker in canine versus human mast cell neoplasms.
De Vos S; Demeyere K; De Cock H; Devriendt N; Schwarzkopf I; Fortrie R; Roggeman T; Meyer E; De Spiegelaere W; de Rooster H
Res Vet Sci; 2022 Dec; 151():90-95. PubMed ID: 35872552
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone.
Webster JD; Yuzbasiyan-Gurkan V; Thamm DH; Hamilton E; Kiupel M
BMC Vet Res; 2008 Aug; 4():32. PubMed ID: 18700956
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and histochemical stains for differentiating canine cutaneous round cell tumors.
Fernandez NJ; West KH; Jackson ML; Kidney BA
Vet Pathol; 2005 Jul; 42(4):437-45. PubMed ID: 16006603
[TBL] [Abstract][Full Text] [Related]
20. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.
Giantin M; Vascellari M; Morello EM; Capello K; Vercelli A; Granato A; Lopparelli RM; Nassuato C; Carminato A; Martano M; Mutinelli F; Dacasto M
J Vet Diagn Invest; 2012 Jan; 24(1):116-26. PubMed ID: 22362941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
